Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Eton Pharmaceuticals shares surged in the last session on above-average trading volume, signaling short-term buying interest. However, recent earnings estimate revisions have not translated into sustained price gains and may limit additional upside in the near term.

Analysis

Eton Pharmaceuticals shares surged in the last session on above-average trading volume, signaling short-term buying interest. However, recent earnings estimate revisions have not translated into sustained price gains and may limit additional upside in the near term.